Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
08/1999
08/11/1999CN1044563C Method for preparing bathing liquor for treating hyperlipemia
08/11/1999CN1044562C Hyptoensive bathing liquor prepn. method
08/11/1999CN1044561C Method for preparing anti-cancer compositions
08/11/1999CN1044560C Method for preparing earthworm fibrinolysis agent
08/10/1999US5936066 Recombinant human interleukin-1α
08/10/1999US5935996 Composition for stimulating osteogenesis and preventingreduction of bone salt
08/10/1999US5935935 Adenoviral vectors for treatment of hemophilia
08/10/1999US5935816 Isolated polynucleotide and process for producing lysyl trna synthetase using host cells and vectors; use is to screen for antibacterial compounds
08/10/1999US5935606 Administering into a region of the central nervous system an adrenal medullary chromaffin cell
08/10/1999US5935575 Interleukin-4 stimulated T lymphocyte cell death for the treatment of allergic disorders
08/10/1999US5935437 Preparation of autologous plasma and fibrin gel
08/10/1999US5935432 Centrifuge reagent delivery system
08/10/1999US5935092 Systems and methods for removing free and entrained contaminants in plasma
08/05/1999WO1999038973A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
08/05/1999WO1999038964A2 Promoter regions of the mouse and human telomerase rna component genes
08/05/1999WO1999038955A2 Mutant herpes simplex viruses and uses thereof
08/05/1999WO1999038954A1 A universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use
08/05/1999WO1999038953A1 Development of regulatory cells as a means for treating autoimmune disease
08/05/1999WO1999038952A2 Cells or tissues with increased protein factors and methods of making and using same
08/05/1999WO1999038525A1 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway
08/05/1999WO1999038520A1 Blood cell composition as a vaccine for hiv and other pathogenic organisms
08/05/1999WO1999038519A1 Anticancer composition
08/05/1999WO1999038518A2 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation
08/05/1999WO1999038380A1 Improved extracorporeal methods for enhancing antigen presentation and immune responsiveness
08/05/1999WO1999025367A3 Treatment of hematologic disorders
08/05/1999WO1999020121A9 Methods for obtaining protein mixtures and control factors from wound granulation, epithelialization or determined blastocyst tissue
08/05/1999WO1997016206A8 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders
08/05/1999DE19803267A1 New method of osteogenesis uses osteoblasts and osteoblast precursors obtained from placental blood
08/05/1999CA2319698A1 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway
08/05/1999CA2319669A1 Mutant herpes simplex viruses and uses thereof
08/05/1999CA2319666A1 Development of regulatory cells as a means for treating autoimmune disease
08/05/1999CA2319117A1 Compounds for therapy and diagnosis of lung cancer and methods for their use
08/05/1999CA2318443A1 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation
08/04/1999EP0933636A1 Rapid extraction of ciguatoxin from contaminated tissues
08/04/1999EP0933429A1 Chimeric poxvirus comprising a retroviral vector genome
08/04/1999EP0933332A1 Electrolysis of water resulting in the reduction of fat content in the human liver
08/04/1999EP0933083A1 Process for the purification of serum albumin
08/04/1999EP0932686A2 Telomerase reverse transcriptase
08/04/1999EP0932668A1 Two human cathepsin proteins
08/04/1999EP0932661A1 Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria
08/04/1999EP0932623A1 Colostrinin, and uses thereof
08/04/1999EP0932418A2 Method for recombinant adeno-associated virus-directed gene therapy
08/04/1999EP0932395A1 Methods and compositions employing red yeast fermentation products
08/04/1999EP0932373A1 Surgical implant containing a resorbable radiopaque marker
08/04/1999CN1225131A Method for treating amyotrophic lateral sclerosis
08/04/1999CN1224623A Compounding method of bone morphogenesis protein to calcined bone
08/04/1999CN1224617A External-use medicine for curing various chronic ulcers
08/04/1999CN1224612A Eye bag & wrinkles eliminating medicine and its preparation
08/04/1999CN1224586A Technological process of producing bifidobacterium beverage using a factor accelerating bifidobacterium growth of peanuts
08/04/1999CN1044479C Process for preparation of anti-thrombin polypeptides
08/04/1999CN1044442C Preparation of Chinese patent drug for treating piles
08/03/1999US5932717 Methods of obtaining DNA-RNA hybrids from sturgeon milt
08/03/1999US5932716 Disclosed herein are methods and compositions for identifying morphogen analogs.
08/03/1999US5932694 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof
08/03/1999US5932537 Contacting a mammalian cell that is responsive to interleukin-1 with an intracellular interleukin-1 receptor antagonist (?icil-1ra?) not normally found in said cell.
08/03/1999US5932470 Ectoparasite saliva proteins and apparatus to collect such proteins
08/03/1999US5932459 Artificial tissues, methods for the production and the use thereof
08/03/1999US5932427 In vitro assay system for identifying compositions useful for stimulating B cells
08/03/1999US5932259 Basic peptide fraction is obtained by hydrolyzing the basic protein fraction with a protease. useful for treating or preventing bone diseases such as osteoporosis.
08/03/1999US5932250 Therapy of vascular disorders
08/03/1999US5932205 Biochemical contact lens for treating photoablated corneal tissue
08/03/1999CA2017039C Gel filtration of heat treated factor viii
08/03/1999CA2002924C Anti-thrombins
07/1999
07/29/1999WO1999037781A1 Mutants of il-16, processes for their production, and their use
07/29/1999WO1999037760A1 Inhibition of cytokine production
07/29/1999WO1999037752A1 Artificial cornea
07/29/1999WO1999037751A1 Purified populations of stem cells
07/29/1999WO1999037332A1 Bone cancer therapy
07/29/1999WO1999037314A1 Sea cucumber carotenoid lipid fraction products and methods of use
07/29/1999WO1999037313A1 Immune effector cell hybrids
07/29/1999WO1999037297A1 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
07/29/1999WO1999025396A3 Hybrid tissues for tissue engineering
07/29/1999WO1998059063A3 Bovine adenovirus type 3 genome
07/29/1999DE19801438A1 Use of phosphodiesterase (PDE) inhibitors to improve sperm motility in insemination and in-vitro fertilization procedures
07/29/1999CA2320624A1 Mutants of il-16, processes for their production, and their use
07/29/1999CA2318987A1 Immune effector cell hybrids
07/29/1999CA2318641A1 Artificial cornea
07/29/1999CA2317839A1 Inhibition of cytokine production
07/29/1999CA2311729A1 Purified populations of stem cells
07/28/1999EP0931830A2 Cytopathic viruses for therapy and phophylaxis of neoplasia
07/28/1999EP0931551A1 Diagnostics and therapeutics for transmissible spongiform encephalopathy and method for the manufacture of non-infective blood products and tissue derived products
07/28/1999EP0931543A1 Multilayered tablet comprising probiotic microorganisms such as lactobacilli or bifidobacteria
07/28/1999EP0931159A2 Non-mammalian dna virus having an altered coat protein
07/28/1999EP0931157A1 Retroviral vectors
07/28/1999EP0931144A1 Novel human phospholemman-like protein
07/28/1999EP0931138A1 Method of producing a thymic microenvironment that supports the development of dendritic cells
07/28/1999EP0930896A1 Method for tolerizing a mammalian patient to administration of gene therapy virus vectors
07/28/1999EP0930894A1 Induction of rev and tat specific cytotoxic t-cells for prevention and treatment of human immunodeficiency virus (hiv) infection
07/28/1999EP0930892A1 Cytokine enhanced immunotherapy for brain tumors
07/28/1999EP0930890A1 USE OF FasL OR FasL TRANSFECTED CD4?+ /FasL?- /TH1-CELL LINES FOR THE TREATMENT OF TH1/TH2 DISEASES
07/28/1999EP0930887A2 Cancer immunotherapy using tumor cells combined with mixed lymphocytes
07/28/1999CN1224428A Cellular injury response element and uses thereof
07/28/1999CN1223883A Anti-lung cancer medicine
07/28/1999CN1223878A Medicinal preparation for treatment of cancer and multiple diseases, and preparing method thereof
07/28/1999CN1223870A 银屑病胶囊 Psoriasis Capsules
07/28/1999CN1223865A Live triple bifidobacteria preparation and preparing method thereof
07/28/1999CN1223864A Biological preparation for treatment of hematopathy
07/28/1999CN1223862A External use medicine for treating open wound
07/28/1999CN1044326C Facial paralysis and hemiplegia pill and preparing method thereof
07/28/1999CN1044325C Medicinal composition for drug dependence and preparing process thereof